Open original FDA record ↗Recall record
- FDA identifier
- Z-0379-2017
- Company in FDA record
- Abbott Laboratories
- FDA classification date
- Nov 9, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Abbott has identified negative interference from the drug N-Acetyl Cysteine (NAC) with the ARCHITECT Lactic Acid reagent (LN 9D89-21).
Source facts
- Action
- Abbott Laboratories sent an Product Correction Immediate Action Required letter dated October 10, 2016, to all affected customers. Please review this letter with your Medical Director Taking the above information into consideration, you may continue to use ARCHITECT Lactic Acid reagent (LN 9D89-21) Please complete and return the Customer Reply Form If you have forwarded the product listed above to other laboratories, please inform them of this Product Correction and provide to them a copy of this letter Please retain this letter for your laboratory records. If you or any of the health care providers you serve have any questions regarding this information, U.S. Customers please contact Customer Service at 1-877-4ABBOTT (available 24 hours a day, 7 days a week). Customers outside the U.S., please contact your local area Customer Service. For further questions please call (847) 937-2550.
- Initiated
- 2016-10-11
- Root cause
- Under Investigation by firm
- Terminated
- 2017-05-17
- Distribution
- Nationwide and Worldwide Distribution.
- Recall number
- Z-0379-2017
- Recall status
- Terminated
- CDRH record ID
- 150391
- FDA classified
- 2016-11-09
- Recall event number
- 75448